Cavalieri, S., Perrone, F., Miceli, R., Ascierto, P., Locati, L., Bergamini, C., Granata, R., Alfieri, S., Resteghini, C., Galbiati, D., Busico, A., Paielli, N., Patuzzo, R., Maurichi, A., Gallino, G., Ruggeri, R., Mariani, L., Palla, M., Licitra, L., & Bossi, P. (2018). efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer. European journal of cancer, 97, 7–15. http://access.bl.uk/ark:/81055/vdc_100065602095.0x00002e